HSP90AA1 and neoplasm: Indeed, immunoprecipitation confirmed that FW-04-806 disrupted Hsp90/Cdc37 chaperone/co-chaperone interactions, leading to enhanced tumor-arresting activity--and caused the degradation of Hsp90 client proteins.